JP2024544623A5 - - Google Patents

Info

Publication number
JP2024544623A5
JP2024544623A5 JP2024531664A JP2024531664A JP2024544623A5 JP 2024544623 A5 JP2024544623 A5 JP 2024544623A5 JP 2024531664 A JP2024531664 A JP 2024531664A JP 2024531664 A JP2024531664 A JP 2024531664A JP 2024544623 A5 JP2024544623 A5 JP 2024544623A5
Authority
JP
Japan
Prior art keywords
virus
cell
srrna
composition
pci
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024531664A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544623A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/080515 external-priority patent/WO2023097317A1/en
Publication of JP2024544623A publication Critical patent/JP2024544623A/ja
Publication of JP2024544623A5 publication Critical patent/JP2024544623A5/ja
Pending legal-status Critical Current

Links

JP2024531664A 2021-11-29 2022-11-28 自己複製rna分子の生成方法 Pending JP2024544623A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163283660P 2021-11-29 2021-11-29
US63/283,660 2021-11-29
PCT/US2022/080515 WO2023097317A1 (en) 2021-11-29 2022-11-28 Methods of generating self-replicating rna molecules

Publications (2)

Publication Number Publication Date
JP2024544623A JP2024544623A (ja) 2024-12-03
JP2024544623A5 true JP2024544623A5 (cg-RX-API-DMAC7.html) 2025-12-08

Family

ID=86540396

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024531664A Pending JP2024544623A (ja) 2021-11-29 2022-11-28 自己複製rna分子の生成方法

Country Status (9)

Country Link
US (1) US20250019745A1 (cg-RX-API-DMAC7.html)
EP (1) EP4441075A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024544623A (cg-RX-API-DMAC7.html)
KR (1) KR20240136943A (cg-RX-API-DMAC7.html)
CN (1) CN118541381A (cg-RX-API-DMAC7.html)
AU (1) AU2022396547A1 (cg-RX-API-DMAC7.html)
CA (1) CA3239025A1 (cg-RX-API-DMAC7.html)
IL (1) IL313199A (cg-RX-API-DMAC7.html)
WO (1) WO2023097317A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120555511A (zh) * 2025-05-29 2025-08-29 杭州依思康医药科技有限公司 一种mRNA转录骨架载体及其在制备自扩增型mRNA疫苗中的应用
CN120924733B (zh) * 2025-10-14 2026-03-10 南京农业大学三亚研究院 一种用于同时检测chikv、bfv、rrv的三重荧光定量pcr检测试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3061826A1 (en) * 2015-02-27 2016-08-31 Novartis AG Flavivirus replicons
AU2019321186B2 (en) * 2018-08-17 2024-05-23 Glaxosmithkline Biologicals Sa Immunogenic compositions and uses thereof
WO2020092387A1 (en) * 2018-10-30 2020-05-07 Nantbio, Inc. Self replicating rna system
WO2020131656A1 (en) * 2018-12-17 2020-06-25 Immune Design Corp. Pathogen-associated molecular pattern molecules and rna immunogenic compositions and methods of using the compositions for treating cancer
AU2022262341A1 (en) * 2021-04-21 2023-09-14 Replicate Bioscience, Inc. Alphavirus vectors containing universal cloning adaptors

Similar Documents

Publication Publication Date Title
US20190216898A1 (en) Interleukin Combination and Use Thereof
Ren et al. Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene–a phase I/II clinical protocol
IL321714A (en) Novel artificial nucleic acid molecules
CN109328233A (zh) 反式复制rna
JPH09511143A (ja) アルファーウイルスcDNAベクター
JPH06508039A (ja) 抗腫瘍治療のためのサイトカインを発現する組換え型欠損アデノウイルス
CN108841796A (zh) 重组单纯疱疹病毒及其制备方法和应用
EP1069908B1 (en) Cancer vaccine comprising alphavirus replicon particles
CN118846113B (zh) 一种偶联CD5抗体的mRNA脂质纳米粒及其应用
Mastrangelo et al. Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors
TW202206448A (zh) 細胞介素免疫療法
KR970705416A (ko) 종양질병 치료용 생백신(live vaccine for the treatment of tumour diseases)
US6844188B1 (en) Methods and modified cells for the treatment of cancer
Roche et al. Semliki Forest virus‐mediated gene therapy of the RG2 rat glioma
US20260109975A1 (en) Self-replicating rna and use thereof
JP2024544623A (ja) 自己複製rna分子の生成方法
CN102038958A (zh) 一种纳米粒子组合物及其应用
Leng et al. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma
Sivanandham et al. Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model
CN117883410A (zh) 包封有mRNA及Acod1基因si-RNA的脂质体纳米颗粒及其应用
WO2020144295A1 (en) Localized administration of rna molecules for therapy
CN101120086A (zh) 用于肿瘤治疗的黄病毒复制子结构
CN116837029A (zh) 表达il-7和gm-csf的sinv载体及其在制备抗肿瘤药物中的应用
JPH08507757A (ja) 腫瘍の治療並びにヒトと動物の免疫化に使用する組成物
CN117143918A (zh) 表达il-7和il-12的sinv载体及其在制备抗肿瘤药物中的应用